We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Merck

News List

Merck to leverage Palantir’s data analytics capabilities pharmaceutical-technology
January 17, 2017
Merck has collaborated with Palantir to leverage the latter’s advanced data analytics capabilities to help it develop and deliver medicines to patients.
Merck Licenses four oncology R&D programs from Vertex cphi-online
January 16, 2017
All programs (two promising clinical-stage programs targeting DNA damage and repair, and two novel pre-clinical programs) have first-in-class and best-in-class potential.
Merck Licenses Four Oncology Research and Development Programs from Vertex americanpharmaceuticalreview
January 13, 2017
Merck KGaA, Darmstadt, Germany, a science and technology company which operates its biopharmaceutical business in the US and Canada as EMD Serono, has entered into a licensing agreement with Vertex Pharmaceuticals Incorporated, Boston, USA, for the

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page